# Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients

> **NCT04049630** · PHASE2 · COMPLETED · sponsor: **Programme National de Lutte contre l'Onchocercose, Republic of the Congo** · enrollment: 255 (actual)

## Conditions studied

- Onchocerciasis, Ocular
- Loiasis

## Interventions

- **DRUG:** LEV 1 mg/kg
- **DRUG:** LEV 1,5 mg/kg
- **DRUG:** LEV 2,5 mg/kg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04049630
- **Lead sponsor:** Programme National de Lutte contre l'Onchocercose, Republic of the Congo
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-16
- **Primary completion:** 2021-04-24
- **Final completion:** 2021-07-15
- **Target enrollment:** 255 (ACTUAL)
- **Last updated:** 2021-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04049630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04049630, "Clinical Trial Evaluating the Safety and Efficacy of Levamisole in Loa Loa Microfilaremic Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04049630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*